Florida Logs 300 Locally Acquired Dengue Cases in 2026, Largest Continental U.S. Outbreak Since 1940s

State data show the outbreak began surfacing in July 2026, prompting local emergencies and round-the-clock aerial and ground spraying in the Tampa area. One death—an elderly Hillsborough resident—occurred on September 4. Most infections involve serotype 1 or 2 among residents lacking prior immunity, producing classic breakbone fever symptoms and occasional hospitalization for dehydration.

Travel from Puerto Rico, where over 1,600 U.S. cases originated this year, supplies the index infections; Aedes aegypti expansion linked to warmer winters amplifies local transmission. Antibody-dependent enhancement risks remain low in this largely naive population, yet the same mechanism complicates future vaccine rollout. CDC surveillance gaps noted in the original report reflect incomplete state-level reporting rather than absence of cases.

Economic modeling from prior Florida outbreaks suggests tourism and outdoor labor sectors could face measurable losses if transmission persists into November. Vector control efficacy data from Miami-Dade's 2023 response indicate that sustained adulticiding plus source reduction cut incidence by roughly 40 percent within eight weeks when coverage exceeds 80 percent of breeding sites.

Next steps require serotype-specific surveillance and evaluation of Wolbachia releases already piloted in Miami. Without these, spillover into neighboring counties remains probable before winter temperatures reduce vector density.